128 related articles for article (PubMed ID: 6142117)
1. (Imidazolylphenyl)formamidines. A structurally novel class of potent histamine H2 receptor antagonists.
Donetti A; Cereda E; Bellora E; Gallazzi A; Bazzano C; Vanoni P; Del Soldato P; Micheletti R; Pagani F; Giachetti A
J Med Chem; 1984 Mar; 27(3):380-6. PubMed ID: 6142117
[TBL] [Abstract][Full Text] [Related]
2. N-(fluoroethyl)(imidazolylphenyl)formamidines. The issue of the active species of mifentidine.
Donetti A; Cereda E; Ezhaya A; Micheletti R
J Med Chem; 1989 May; 32(5):957-61. PubMed ID: 2565401
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of mifentidine, a novel H2-receptor antagonist.
Pagani F; Micheletti R; Brambilla A; Schiavone A; Montagna E; Ciprandi C; Giachetti A
Arzneimittelforschung; 1985; 35(1A):451-5. PubMed ID: 2859036
[TBL] [Abstract][Full Text] [Related]
4. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
5. Substituent effect on the stereochemistry of H2-receptor antagonists of the phenylformamidine series. A conformation-dependent mode of interaction with the H2 receptor.
Donetti A; Bastiaans HM; Kramer K; Bietti G; Cereda E; Dubini E; Mondoni M; Bast A; Timmerman H
J Med Chem; 1991 Jun; 34(6):1772-6. PubMed ID: 1676425
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of novel compounds interacting with H2-histamine receptors: effect on histamine-sensitive adenylate cyclase activity in guinea-pig gastric mucosa.
Micheletti R; Oliva D; Belfiore P; Giachetti A; Nicosia S
Agents Actions; 1985 Jul; 16(5):291-4. PubMed ID: 2864816
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and assessment of formamidines as new histamine H2-receptor antagonists.
Anglada L; Raga M; Márquez M; Sacristán A; Castelló JM; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):431-4. PubMed ID: 9205738
[TBL] [Abstract][Full Text] [Related]
8. Bioisosteric prototype design of biaryl imidazolyl and triazolyl competitive histamine H2-receptor antagonists.
Lipinski CA; LaMattina JL; Oates PJ
J Med Chem; 1986 Nov; 29(11):2154-63. PubMed ID: 2878075
[TBL] [Abstract][Full Text] [Related]
9. Histamine H2 receptor antagonists. 1. Synthesis of N-cyano and N-carbamoyl amidine derivatives and their biological activities.
Yanagisawa I; Hirata Y; Ishii Y
J Med Chem; 1984 Jul; 27(7):849-57. PubMed ID: 6145803
[TBL] [Abstract][Full Text] [Related]
10. Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs.
Shibata M; Yamaura T; Inaba N; Onodera S; Chida Y; Ohnishi H
Eur J Pharmacol; 1993 Apr; 235(2-3):245-53. PubMed ID: 8099553
[TBL] [Abstract][Full Text] [Related]
11. Conformational requirements for histamine H2-receptor inhibitors: a structure-activity study of phenylene analogues related to cimetidine and tiotidine.
Hoffman JM; Pietruszkiewicz AM; Habecker CN; Phillips BT; Bolhofer WA; Cragoe EJ; Torchiana ML; Lumma WC; Baldwin JJ
J Med Chem; 1983 Feb; 26(2):140-4. PubMed ID: 6131129
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological profile of mifentidine: a novel H2-receptor antagonist.
Giachetti A; Pagani F; Micheletti R; Brambilla A; Cereda E; Donetti A
Agents Actions; 1985 Apr; 16(3-4):173-5. PubMed ID: 2861730
[TBL] [Abstract][Full Text] [Related]
13. Studies on histamine H2 receptor antagonists. 2. Synthesis and pharmacological activities of N-sulfamoyl and N-sulfonyl amidine derivatives.
Yanagisawa I; Hirata Y; Ishii Y
J Med Chem; 1987 Oct; 30(10):1787-93. PubMed ID: 2888895
[TBL] [Abstract][Full Text] [Related]
14. Pseudosymmetry and bioisosterism in biaryl pyridyl competitive histamine H2-receptor antagonists.
Lipinski CA; LaMattina JL; Hohnke LA
J Med Chem; 1985 Nov; 28(11):1628-36. PubMed ID: 2866245
[TBL] [Abstract][Full Text] [Related]
15. Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidine.
Durant GJ; Emmett JC; Ganellin CR; Miles PD; Parsons ME; Prain HD; White GR
J Med Chem; 1977 Jul; 20(7):901-6. PubMed ID: 17751
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of etintidine, a new histamine H2-receptor antagonist.
Scott CK; Katz LB; Shriver DA
Arch Int Pharmacodyn Ther; 1986 May; 281(1):5-21. PubMed ID: 2875695
[TBL] [Abstract][Full Text] [Related]
17. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cimetidine with new H2-antagonists in rabbit and guinea pig gastric cells.
Batzri S; Harmon JW; Toles R
Eur J Pharmacol; 1983 Oct; 94(1-2):1-8. PubMed ID: 6140169
[TBL] [Abstract][Full Text] [Related]
19. Characterization and development of cimetidine as a histamine H2-receptor antagonist.
Brimblecombe RW; Duncan WA; Durant GJ; Emmett JC; Ganellin CR; Leslie GB; Parsons ME
Gastroenterology; 1978 Feb; 74(2 Pt 2):339-47. PubMed ID: 23336
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
